deaths (OS)

mNSCLC - L2 - all population metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) mNSCLC - L2 - all population

versus docetaxel
atezolizumab alone vs. docetaxel 2 0.79 [0.70; 0.89], 2 RCTs, I2=0% conclusive
moderate degree of certainty